2026-01-22 - Analysis Report
**UnitedHealth Group (UNH) Financial Report**

**Company Overview**
UnitedHealth Group is a multinational healthcare company providing health insurance and health services.

**Return Rate Comparison**

* Cumulative return of review stock (UNH): -17.56%
* Cumulative return of comparison stock (S&P 500, VOO): 91.55%
* Divergence (max: 29.90, min: -124.60, current: -114.80, relative divergence: 6.30%)

The stock price of UNH has underperformed compared to the S&P 500 index, with a cumulative return of -17.56% versus 91.55%.

**Alpha, Beta Analysis**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2016-2018  | 22.0% | 18.6% | 18.0% | 0.9 | 225.7B |
| 2017-2019  | 27.0% | 18.6% | 10.0% | 0.9 | 266.3B |
| 2018-2020  | -41.0% | 32.5% | -62.0% | 1.1 | 317.7B |
| 2019-2021  | 16.0% | 32.5% | -27.0% | 1.1 | 454.9B |
| 2020-2022  | 0.0% | 31.5% | 2.0% | 0.9 | 480.3B |
| 2021-2023  | 23.0% | 13.4% | 23.0% | 0.5 | 476.9B |
| 2022-2024  | -24.0% | 23.1% | -44.0% | 0.4 | 458.2B |
| 2023-2025  | -55.0% | 58.5% | -118.0% | 0.3 | 299.0B |

**Recent Stock Price Fluctuations**

* Close: $347.75 
* Last-market: +2.75 (+0.79%)
* 5-day SMA: $338.22
* 20-day SMA: $336.30
* 60-day SMA: $333.21

The stock price of UNH has shown a moderate increase in recent days, with a 5-day SMA at $338.22 and a 20-day SMA at $336.30.

**RSI, PPO Index Indicators and Delta_Previous_Relative_Divergence**

* Market Risk Indicator (MRI): 0.80 (Medium Investment)
* RSI: 60.26 (Neutral)
* PPO: 0.07 (Bearish)
* Hybrid Signal: Buy (Cash 0%)
Risk Level: Medium (MRI 0.80)
Recent relative divergence change: -1.60 (Worsening)
7-day Rank change: 46 (Rank up)
7-day Dynamic Expected Return change: -58.80 (Worsening)
Expected Return (%): -356.70%

The stock price of UNH has shown a bearish trend in recent days, with a PPO indicator at 0.07 and an Expected Return of -356.70%.

**Recent News & Significant Events**

* 2026-01-04: Don't Buy UnitedHealth Group Stock Before Jan. 27 - The Motley Fool
* 2026-01-04: Don't Buy UnitedHealth Group Stock Before Jan. 27 - Yahoo Finance
* 2026-01-21: UnitedHealth rebating profits from ACA plans to customers (UNH:NYSE) - Seeking Alpha
* 2026-01-21: UnitedHealth Group (NYSE:UNH) Stock Price Up 2.3% - Here's Why - MarketBeat
* 2026-01-15: UNH Stock vs. CVS - Forbes
* 2026-01-20: UnitedHealth Group Stock (UNH) Opinions on Senate Medicare Report - Quiver Quantitative

**Analyst Opinions**

* Analyst Consensus:
	+ Key: Buy
	+ Mean (1=StrongBuy~5=Sell): 1.93 (~Buy)
	+ Opinions: 26
	+ Target Price (avg/high/low): 393.85 / 444.00 / 280.00

The average opinion of analysts is to Buy, with a mean rating of 1.93 and a target price of $393.85.

**Recent Earnings Analysis**

| Date | EPS | Revenue |
|---|---:|---:|
| 2025-10-28 | 2.59 | $113.16 B$ |
| 2025-08-11 | 3.76 | $111.62 B$ |
| 2025-05-07 | 6.9 | $109.58 B$ |
| 2024-11-04 | 6.56 | $100.82 B$ |
| 2025-10-28 | 6.56 | $100.82 B$ |

The earnings of UNH have been mixed, with a positive EPS growth in recent quarters but a flat revenue growth.

**Financial Information - Revenue and Profitability**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $113.16B | 18.24% |
| 2025-06-30 | $111.62B | 17.93% |
| 2025-03-31 | $109.58B | 21.70% |
| 2024-12-31 | $100.81B | 21.14% |
| 2024-09-30 | $100.82B | 22.84% |

The revenue of UNH has been stable, with profit margins ranging from 17.93% to 21.70%.

**Financial Information - Capital and Profitability**

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $95.79B | 2.45% |
| 2025-06-30 | $94.72B | 3.60% |
| 2025-03-31 | $95.04B | 6.62% |
| 2024-12-31 | $92.66B | 5.98% |
| 2024-09-30 | $94.53B | 6.41% |

The equity of UNH has been mostly stable, with ROE ranging from 2.45% to 6.62%.

**Comprehensive Analysis (Summary of previous items)**

The stock price of UNH has underperformed compared to the S&P 500 index, with a cumulative return of -17.56% versus 91.55%. The recent stock price fluctuations have shown a moderate increase, but the PPO and Expected Return indicators suggest a bearish trend. The earnings and financial information of UNH have been mixed, with a stable revenue and profit margins but a variable equity and ROE. The analyst opinions suggest a Buy rating, but the current market risk is Medium.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.